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Terahertz and infrared spectroscopy are effective analytical spectroscopic 
techniques to identify and study the conformation and molecular interaction of the 
biomolecules. It has a huge potential in cancer diagnosis because these spectroscopies 
are non-invasive technique and do not require labelling for tissues and cells. 
Volatolomics analysis is a technique to analyse the volatile organic compounds 
(VOCs) emitted and released by human metabolites, which are not limited to breathe 
analysis. VOCs that are released by cancerous cells can be one of the bio-diagnostics 
techniques to diagnose cancer. Although studies on breath analysis have been widely 
carried out, the study of the volatolomics analysis by using Fourier transform infrared 
spectroscopy (FTIR) and Terahertz time-domain spectroscopy (THz-TDS) is still new. 
Both FTIR and THz-TDS instruments are installed with a gas cell sampling tools by 
absorption technique to analyse and detect the key species released from the VOCs. 
Lung cancer (NCL-H1299) and colon cancer (COLO320DM) cell lines are uas 
samples to identify the key species of each of the cancerous cells. The experiment has 
been verified and validated by comparing with control samples such as normal lung 
(MRC-5) cell lines, normal colon (CCD112CoN) cell lines, empty flask, air from the 
culture media and normal lab air. All the samples have been cultured into different 
sealed flasks for 24 to 120 hours, before the VOCs are collected and transferred into 
the gas cells to analyse using FTIR and THz-TDS. Hydrogen chloride and benzamide 
have been identified as key species for lung and colon cancer, respectively. These 
findings have been verified and validated by using residual gas analyser (RGA), gas 
chromatography – mass selective detector (GC-MSD), and confirmed by earlier 
literatures. A chemometric statistical analysis also has been applied to this study to 
extract the important information of the biochemical data from the VOCs with the 
greatest discriminative power and highest precision. These findings demonstrate the 
potential use of FTIR and THz-TDS as clinical tools through the volatolomics analysis. 
In addition, more work is needed if it is to be applied in clinical practice. 
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Spektroskopi terahertz dan inframerah merupakan teknik spektroskopik 
analitikal yang efektif dalam mengenalpasti dan mengkaji struktur interaksi molekul 
bagi sesuatu biomolekul. Ia merupakan potensi yang besar dalam proses diagnosis 
kanser kerana teknik spektroskopik ini adalah tidak invasif dan tidak memerlukan 
pelabelan untuk tisu dan sel. Analisis volatolomik pula merupakan satu teknik untuk 
menganalisis sebatian organik yang mudah meruap (VOCs) yang terhasil daripada 
proses metabolisme manusia, yang mana tidak terhad kepada analisis pernafasan 
sahaja. VOCs yang dihasilkan oleh sel kanser boleh menjadi salah satu teknik bio-
diagnostik sel kanser. Walaupun kajian mengenai analisis pernafasan telah banyak 
dijalankan, tetapi kajian analisis volatolomik dengan mengunakan spektroskopi infra 
merah transformasi Fourier (FTIR) dan spektroskopi Terahertz domain masa (THz-
TDS) masih baru. Kedua-dua instrument FTIR dan THz-TDS telah dipasangkan pada 
satu alat persampelan sel gas melalui teknik penyerapan untuk menganalisa dan 
mengesan spesies petunjuk daripada VOCs yang dilepaskan. Titisan sel-sel bagi 
kanser paru-paru (NCL-H1299) dan kanser kolon (COLO320DM) digunakan di dalam 
kajian ini untuk mengesan spesies petunjuk bagi setiap kanser. Ujikaji yang dijalankan 
telah diverifikasi dan divalidasi dengan membandingkan sampel terkawal seperti 
titisan sel paru-paru normal (MRC-5), sel kolon normal (CCD112CoN), udara 
kelalang kosong, udara daripada medium kultur dan udara persekitaran makmal. 
Semua sampel titisan sel telah dikultur melalui kelalang-kelalang yang kedap yang 
berbeza selama 24 jam hingga 120 jam, sebelum VOCs dikumpul dan dipindahkan ke 
sel-sel gas untuk dianalisis menggunakan FTIR dan THz-TDS. Hidrogen klorida dan 
benzamida telah dikenalpasti sebagai spesies petunjuk bagi kanser paru-paru dan 
kanser kolon. Penemuan ini telah diverifikasi dan divalidasi dengan menggunakan 
penganalisis gas sisa (RGA), kromatografi gas – pengesan jisim terpilih (GC-MSD) 
dan disahkan oleh literature terdahulu. Satu statistikal analisis kemometri juga 
diterapkan untuk kajian ini bagi mengekstrak maklumat penting data biokimia 
daripada VOCs dengan kuasa diskrimitif terbesar dan kepersisan tertinggi. Hasil kajian 
ini menunjukkan potensi penggunaan FTIR dan THz-TDS sebagai peralatan klinikal 
menerusi analisis volatolomik. Di samping itu, kajian lanjut masih diperlukan jika ia 
ingin diaplikasikan di dalam amalan klinikal. 
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INTRODUCTION 
1.1 Overview 
This introductory chapter illustrates the core of this study, including the 
background which stimulates this research work, the motivation for the focus of the 
work which highlighted the importance of the volatolomics analysis used in disease 
and cancer diagnosis, the problem statement, aim and objectives, scope, and 
significance of the study. This chapter is structured to introduce the huge potential of 
cancer detection through volatolomics analysis using Fourier transform infrared 
spectroscopic and Terahertz time-domain spectroscopy technique.  
1.2 Background of the Study 
Cancer is a major cause of mortality in this world with more than half a million 
deaths by the year 2013 in the United States alone, and the number of cancer cases are 
increasing every year, especially in the low and mid-income countries [1]. The 
imbalanced socio-economics from these countries led to lack of awareness, expertise 
and equipment to diagnose the cancer accurately, in short duration and cost effective 
manners. 
2 
In general, cancer can be diagnosed by invasive and non-invasive techniques. 
The invasive techniques, such as biopsy and endoscopy, involve making an incision in 
the body to gain access to the target area. The non-invasive techniques, such as 
imaging and laboratory testing, do not involve surgical procedures. There also are 
alternative techniques to detect and identify the cancer, such as breath analysis [2], 
chemometric analysis [3], bio-fluids analysis [4]s and others.  
Fourier transform infrared spectroscopy (FTIR) and Terahertz time-domain 
spectroscopy (THz-TDS) based technique in cancerous tissue diagnostic are dependent 
on terahertz and infrared spectral analysis between healthy and cancerous tissue 
samples. However, spectrum broadening is the most challenging to determine [5,6]. 
The broadening character of the terahertz and infrared spectrum in particular recorded 
from liquid or solid samples can mask and also interfere with other cancerous tissue 
constituents, including water spectrum thus affecting the measurement resolution. 
Detection of volatile organic compounds (VOCs) produced by cancerous cell can be a 
better option as the terahertz and infrared spectrum of the gas exhibit less broadening 
character. 
This approach allows for a better terahertz and infrared spectrum of key 
products of the VOCs to be identified [7,8]. This key product then can be used as a 
fingerprint for that particular cancer type. Other diagnostic tools have not been able to 
yield the biochemical information to identify the key species of the cancer. Even so, 
the current techniques to detect the cancer have many disadvantages, such as high cost, 
many procedure, contamination or side effects. The proposed techniques using FTIR 
and THz-TDS complement the other techniques in assisting the physician to diagnose 
the cancer effectively. 
In this study, the development of cancer fingerprints uses FTIR and THz-TDS 
is to identify the key species of volatile organic compounds (VOCs). This approach 
will utilize the gas released from cancerous cell, which contains VOCs, and infrared 
light absorbance to monitor specific absorbance patterns which produced the following 
changes in chemical compound species: for example, 6-aldehydes, isoprene, n-butyl 
3 
acetate, and n-propyl propionate released by hepatocellular carcinoma cell using GC-
MS [9]. 
1.3 Motivation of the Work 
This study involves three key aspects: (i) developing a system to capture and 
measure the volatile organic compounds released by cancerous cells, (ii) measuring 
and identifying the key species, and (iii) verifying and validating the key species of 
the cancer. The following sub-section highlight the significance of the study and the 
importance of the current work. 
1.3.1 Why is volatolomics analysis used in cancer diagnosis? 
Volatolomics analysis is the examination of the volatile organic compounds 
(VOCs) released by all metabolites from living things for the presence of certain 
compounds to determine the presence of cancers or diseases of the human body.  
Volatolomics analysis is not limited to breath analysis, but it is covered the VOCs 
released from breath, sweat, skin, urine, faeces and vaginal secretions.  Volatolomics 
analysis has huge potential in detection and identification of diseases and cancer 
diagnosis [10,11], especially when it is involved in the end products of cellular 
processes of the human as well as a non-destructive technique. 
There are many advantages by using Volatolomics analysis to diagnose the 
cancerous or diseases samples compared to other conventional methods; for example, 
this analysis technique is a non-invasive method which may reduce the risks and be 
less harmful to the patient and personnel. Furthermore, the results can also analyze and 
appear immediately if we have an established database of the diseases. 
4 
1.3.2 Why should a volatolomics analysis system be developed? 
This volatolomics analysis technique will assist physicians and medical experts 
to diagnose the cancer or other diseases effectively. The non-destructive sample 
collection technique will help some patients who have problems with conventional 
sampling and diagnostics technique. 
1.4 Problem Statement 
The VOCs released by cancerous cells can be one of the bio-diagnostics 
techniques to diagnose the cancer. Previous works on VOCs detection released by 
cancerous cells have been performed by using a few analytical instruments, such as 
gas chromatography – mass spectrometer (GS-MS), electronic nose, proton transfer 
reaction mass spectrometry (PTR-MS), selected ion flow tube – mass spectrometry 
(SIFT-MS) and ion mobility spectrometry (IMS). However, each of these analytical 
instruments had their limitations, such as the need to change the filters, cannot measure 
in real time and simultaneously, need sample preparations, not effective and time 
consuming. Fourier transform infrared spectroscopy (FTIR) and Terahertz time-
domain spectroscopy (THz-TDS) with gas absorption sampling techniques can 
overcome this limitation. The key species from VOCs released by cancerous cells can 
be identified and obtained from the literatures and National Institute of Science and 
Technology (NIST) [12] databases. The key species will be verified with other gas 
recognition technique and validated with the literature. Then, the samples are analysed 
by using chemometric statistical analysis technique for the highest discrimination and 
precision of results. 
5 
1.5 Objectives 
The aim of this study was to carry out a detailed study of the application of 
Fourier transform infrared spectroscopy (FTIR) and Terahertz time-domain 
spectroscopy (THz-TDS) as potential diagnostics tools for clinical use for detection of 
cancer through volatolomics analysis. The study shows the application of FTIR and 
THz-TDS as a method to characterise biochemical differences that detect and 
distinguish the volatile organic compounds released by cancerous cells. This is based 
on the FTIR and THz-TDS analytical instruments measurements and statistical 
analysis of lung and colon cancer cell lines as well as normal cell lines and control 
experiment. 
The study aims to address the following objectives: 
a) To develop a technique to capture and measure the volatile organic 
compounds (VOCs) from lung and colon cancer cell lines 
b) To measure and identify the key species of the samples using Fourier 
transform infrared spectroscopy (FTIR) and Terahertz time-domain 
spectroscopy (THz-TDS) 
c) To analyse the samples using chemometric analysis and validate the key 
species 
1.6 Scope of Study 
This study is focused on identification of two types of cancer fingerprint, such 
as lung and colon cancer, through release and uptake of volatile organic compounds 
by cell lines by using Fourier transform infrared spectroscopy (FTIR) and Terahertz 
time-domain spectroscopy (THz-TDS). 
6 
This study consists of four parts of science and mathematics areas. Firstly, the 
concept of physics radiation of infrared and terahertz for detection of the samples. 
Second is biomedical samples, such as cancerous cell lines, to be detected and 
identified by the analytical instruments. Thirdly, the chemical compounds need to be 
identified as key species of the particular cancer from the volatile organic compounds 
(VOCs). Fourth is the mathematical statistical analysis of the sample for the highest 
discrimination and accuracy of the samples by using chemometric analysis. 
1.7 Significance and Original Contributions of This Study 
Detection and identification of cancer fingerprints are very important and have 
a high impact to the community. In this world of health and medical practice, fast 
techniques, cost-effective and accurate detection and identification of diseases and 
cancer is very crucial to assist the medical practitioner. The cancer also affects human 
health and causes the most human mortality every year, worldwide. In addition, 
research on identification of cancer fingerprint through release and uptake of volatile 
organic compounds using analytical spectroscopy instruments such as FTIR and THz-
TDS is still new and not established yet. 
The spectroscopic analytical instruments, such as FTIR and THz-TDS, with a 
combination of gas cell sampling tools and the analytical capabilities of this 
combination were demonstrated by simultaneous in vitro gas monitoring and detection 
of cancerous cells. Furthermore, assistance of chemometric analysis technique will 
provide the highest discriminative power and highest precision of the result. 
The THz-TDS with gas analysis technique is a preliminary study to identify 
the cancer key species through volatile organic compounds (VOCs). The terahertz 
spectroscopy technique can capture the signal directly, simultaneously and effective 
7 
from the samples.  All of the key species will be saved into a database and can be used 
as cancer identifier for patient using mobile THz-TDS – gas analyzer in the near future. 
1.8 Thesis Structure and Organization 
Chapter 2 of this thesis reviews the literature highlighting applications of FTIR 
and THz-TDS in biomedicine, cancer identification and volatolomics analysis. This 
includes detailed discussion on spectroscopic studies in various diseases in human 
tissues, cells and bio-fluids. This is followed by an outline of the methodology and 
materials used for analysis and identification of cancerous cells in Chapter 3. This 
chapter also covers system optimization and data analysis. The results are presented in 
Chapter 4 with discussion as the data was analysed. This chapter is divided into three 
sections, presenting and discussing results from a) cell lines analysis, b) detection of 
key species, and c) verification and validation. The conclusions drawn from the work 
will follow in Chapter 5 with suggestions for future work. 
1.9 Summary 
This chapter summarizes the foundation of this study to make sure this study 
will be achieved within the prescribed scope. Two types of cancerous cells will be 
investigated in this study, namely colon and lung cancer. Fourier transform infrared 
spectroscopy (FTIR) and Terahertz time-domain spectroscopy (THz-TDS) is used as 
analytical instruments. Chemometric analysis is also used to refine and to determine 
the highest discrimination and accuracy of the results.
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